Etienne Caron, PhD
Assistant ProfessorCards
Appointments
Contact Info
About
Titles
Assistant Professor
Biography
Dr. Caron is a Canadian scientist with a background in Biotechnology and Systems Immunology. He received his PhD from the University of Montreal and completed his education at ETH-Zürich in Switzerland under the guidance of Dr. Ruedi Aebersold. Dr. Caron is known for his international leadership and expertise in immunopeptidomics for the global analysis of MHC-associated peptides using mass spectrometry technologies. His scientific program has the potential to revolutionize the research on vaccine design, cancer immunotherapy, infectious and autoimmune diseases, including treatment of neurodegenerative diseases and aging.
Dr. Caron began his career as a Principal Investigator in 2018 at the University of Montreal, Canada, with the goal of making the field of immunopeptidomics as transformative as cancer genomics to create new paradigms in immunology & immunotherapy to improve patient care worldwide.
In 2023, Dr. Caron was recruited by the Yale Center for Immuno-Oncology (YCIO) and the Department of Immunobiology. He is also currently a member of the Yale Center for Infection and Immunity (CII), and the Yale Center for Systems and Engineering Immunology (CSEI).
Dr. Caron is co-founder and former chair (2015-2020) of the Human Immunopeptidome Project. He also co-founded the start-up Neomabs Biotechnologies Inc., with the goal of transforming the treatment of childhood leukemia through targeted immunotherapies. Dr. Caron has also provided distinctive services to the life sciences industry through numerous collaborations with companies such as Biognosys, ImmunXperts, CellCarta, Genentech, and Flagship Pioneering.
Appointments
Immunobiology
Assistant ProfessorPrimary
Other Departments & Organizations
Education & Training
- Postdoctoral Fellow
- ETH Zürich (2018)
- Postdoctoral Fellow
- EMBL Barcelona (2012)
- PhD
- University of Montreal (2011)
- Japan Society for the Promotion of Science (JSPS) Fellow
- University of Tokyo (2009)
- MSc
- University of Montreal (2005)
- BSc
- University of Sherbrooke (2001)
- B.Sc. Industrial work terms
- Shire Biochem (2001)
Research
Overview
Medical Subject Headings (MeSH)
ORCID
0000-0003-2770-6970- View Lab Website
Caron Lab
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Yansheng Liu, PhD
Matthew Vesely, MD, PhD
Mass Spectrometry
Proteomics
HLA Antigens
Antigen Presentation
Computational Biology
Systems Biology
Publications
2023
Scaling up robust immunopeptidomics technologies for a global T cell surveillance digital network
Kapoor S, Maréchal L, Sirois I, Caron É. Scaling up robust immunopeptidomics technologies for a global T cell surveillance digital network. Journal Of Experimental Medicine 2023, 221: e20231739. PMID: 38032361, PMCID: PMC10689202, DOI: 10.1084/jem.20231739.Peer-Reviewed Original ResearchCitationsAltmetricMeSH KeywordsThe SysteMHC Atlas v2.0, an updated resource for mass spectrometry-based immunopeptidomics
Huang X, Gan Z, Cui H, Lan T, Liu Y, Caron E, Shao W. The SysteMHC Atlas v2.0, an updated resource for mass spectrometry-based immunopeptidomics. Nucleic Acids Research 2023, 52: d1062-d1071. PMID: 38000392, PMCID: PMC10767952, DOI: 10.1093/nar/gkad1068.Peer-Reviewed Original ResearchCitationsAltmetricIntegrated Immunopeptidomics and Proteomics Study of SARS-CoV-2–Infected Calu-3 Cells Reveals Dynamic Changes in Allele-specific HLA Abundance and Antigen Presentation
Chen R, Fulton K, Tran A, Duque D, Kovalchik K, Caron E, Twine S, Li J. Integrated Immunopeptidomics and Proteomics Study of SARS-CoV-2–Infected Calu-3 Cells Reveals Dynamic Changes in Allele-specific HLA Abundance and Antigen Presentation. Molecular & Cellular Proteomics 2023, 22: 100645. PMID: 37709257, PMCID: PMC10580047, DOI: 10.1016/j.mcpro.2023.100645.Peer-Reviewed Original ResearchAltmetricConceptsSARS-CoV-2 infectionHuman leukocyte antigenAdaptive immune systemHLA allelesAntigen presentationAcute respiratory syndrome coronavirus 2 infectionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionImmune systemSyndrome coronavirus 2 infectionCoronavirus disease 2019 (COVID-19) casesHost proteome changesCoronavirus 2 infectionCertain HLA allelesToll-like receptorsDifferent HLA allelesCoronavirus disease 2019Calu-3 cellsHost cellsLeukocyte antigenViral antigensDisease 2019Viral infectionDevelopment of therapeuticsInfectionClass IUnlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery
Stutzmann C, Peng J, Wu Z, Savoie C, Sirois I, Thibault P, Wheeler A, Caron E. Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery. Cell Reports Methods 2023, 3: 100511. PMID: 37426761, PMCID: PMC10326451, DOI: 10.1016/j.crmeth.2023.100511.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSingle-cell proteomicsMicrofluidic technologyPotential of microfluidicsMass spectrometrySample preparationDroplet microfluidicsDigital microfluidicsMicrofluidic methodPhysical moleculesMicrofluidicsHigh sensitivityReproducible mannerPillar arraysRecent advancesSpectrometryMoleculesImmunopeptidomicsPowerful toolProteomicsPreparationMSPeptidesSolutionIntroduction to the Special Issue: The Immunopeptidome
Caron É, Perreault C. Introduction to the Special Issue: The Immunopeptidome. Seminars In Immunology 2023, 69: 101798. PMID: 37348326, DOI: 10.1016/j.smim.2023.101798.Peer-Reviewed Original ResearchAltmetricMeSH Keywords
2022
Cellular senescence is immunogenic and promotes anti-tumor immunity
Marin I, Boix O, Garcia-Garijo A, Sirois I, Caballe A, Zarzuela E, Ruano I, Attolini C, Prats N, López-Domínguez J, Kovatcheva M, Garralda E, Muñoz J, Caron E, Abad M, Gros A, Pietrocola F, Serrano M. Cellular senescence is immunogenic and promotes anti-tumor immunity. Cancer Discovery 2022, 13: 410-431. PMID: 36302218, PMCID: PMC7614152, DOI: 10.1158/2159-8290.cd-22-0523.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCD8 T cellsAntitumor immune responseImmunogenic cell deathDendritic cellsSenescent cancer cellsT cellsCancer cellsImmune responseAntigen-specific CD8 T cellsSenescent cellsRelease of alarminsAnti-tumor immunityInnate immune cellsHuman primary cancer cellsActivation of IFNCellular senescencePrimary cancer cellsAdaptive immune systemCell deathCD8 lymphocytesAntitumor protectionImmune cellsImmune systemContext of cancerInduction of senescencePopulation Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages
Mostefai F, Gamache I, N'Guessan A, Pelletier J, Huang J, Murall CL, Pesaranghader A, Gaonac'h-Lovejoy V, Hamelin DJ, Poujol R, Grenier JC, Smith M, Caron E, Craig M, Wolf G, Krishnaswamy S, Shapiro BJ, Hussin JG. Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages. Frontiers In Medicine 2022, 9: 826746. PMID: 35265640, PMCID: PMC8899026, DOI: 10.3389/fmed.2022.826746.Peer-Reviewed Original ResearchCitationsAltmetricConceptsPopulation genomic approachesStandard phylogenetic approachesGenome sequencing dataHaplotype networkGenomic approachesPhylogenetic approachTajima's DHigh-quality consensus sequencesGenetic diversityPopulation geneticsGenomic variationConsensus sequenceLineage expansionSequencing dataSARS-CoV-2 diversityGenetic characterizationLineage identificationDiversity landscapeInfection pathwaySARS-CoV-2 lineagesRecurrent mutationsGISAID databaseSARS-CoV-2DiversityPathogensUnderstanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues
Kubiniok P, Marcu A, Bichmann L, Kuchenbecker L, Schuster H, Hamelin D, Duquette J, Kovalchik K, Wessling L, Kohlbacher O, Rammensee H, Neidert M, Sirois I, Caron E. Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues. IScience 2022, 25: 103768. PMID: 35141507, PMCID: PMC8810409, DOI: 10.1016/j.isci.2022.103768.Peer-Reviewed Original ResearchCitationsAltmetric
2021
Generation of HLA Allele-Specific Spectral Libraries to Identify and Quantify Immunopeptidomes by SWATH/DIA-MS
Kovalchik K, Hamelin D, Caron E. Generation of HLA Allele-Specific Spectral Libraries to Identify and Quantify Immunopeptidomes by SWATH/DIA-MS. Methods In Molecular Biology 2021, 2420: 137-147. PMID: 34905171, DOI: 10.1007/978-1-0716-1936-0_11.Peer-Reviewed Original ResearchCitationsAltmetricMhcVizPipe: A Quality Control Software for Rapid Assessment of Small- to Large-Scale Immunopeptidome Datasets
Kovalchik K, Ma Q, Wessling L, Saab F, Duquette J, Kubiniok P, Hamelin D, Faridi P, Li C, Purcell A, Jang A, Paramithiotis E, Tognetti M, Reiter L, Bruderer R, Lanoix J, Bonneil É, Courcelles M, Thibault P, Caron E, Sirois I. MhcVizPipe: A Quality Control Software for Rapid Assessment of Small- to Large-Scale Immunopeptidome Datasets. Molecular & Cellular Proteomics 2021, 21: 100178. PMID: 34798331, PMCID: PMC8717601, DOI: 10.1016/j.mcpro.2021.100178.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsModern web browsersLarge-scale datasetsQuality control softwareWeb browserHTML formatControl softwareSoftware toolsProteomics core facilitiesConsolidated viewDatasetImmunopeptidomic datasetsHigh-throughput technologiesDecision-making processData interpretationBrowserInstrument operatorsComputerAssurance systemAlgorithmQuality controlSoftwareCore facilitiesFormatServicesTechnology
Academic Achievements and Community Involvement
honor Effervescence Stars Award
International AwardMontreal In VivoDetails05/15/2023Canadahonor Research Scholars - Junior 2
International AwardFRQSDetails03/06/2023Canadahonor Bravo Recherche – COVID edition
International AwardUniversité de MontréalDetails02/09/2021Canadahonor Research Scholars - Junior 1
International AwardFRQSDetails04/01/2019Canadahonor Marie-Curie Intra-European Fellowship
International AwardEuropean ComissionDetails04/01/2013Switzerland
Links & Media
Media
(A) World map illustrating the ambition of profiling immunopeptidomes across human populations using advanced immunopeptidomics technologies. A microfluidic device for automated sample preparation and a mass spectrometer for data acquisition are shown as representative examples of technologies that will be further developed. (B) Schematic of the workflow to identify immunopeptidomic signatures of disease susceptibility/resistance to stratify patients and help personalize mitigation strategies in future pandemics. SARS-CoV-2 is used for illustrating the concept. In this example, viral peptides are isolated at population-scale from plasma samples (patient cohorts). Fictive bar plot of HLA-I-allele-specific self peptides in different organs (patient #1) and population-scale quantitative digital maps of soluble HLA-associated SARS-CoV-2 peptides from plasma samples are illustrated.
Related Links
- Pondering the power of connections in the post–COVID-19 era
- Launches of Neomabs Biotechnologies, a Company Dedicated to Developing New Immunotherapies For Cancer Treatment
- Effects of SARS-CoV-2 mutations on immune response
- To Investigate or Not to Investigate? Researchers' Views on Unexplored Atmospheric Light Phenomena
Get In Touch
Contacts
Locations
Caron Lab
Academic Office
300 George Street, Fl 3rd, Rm 353G
New Haven, CT 06511